Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell C Dale

Showing results (271-280 of 353) with videos related to

Pageof 36
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 8, 2026
Cumulative environmental exposures adversely impact social behaviour and are associated with dysregulation of genes and proteins involved in epigenetic, ribosomal, and immune regulation in male miceMorgan C Bucknor, Brooke A Keating, Velda X Han, et al.
Cell Reports. Medicine|January 20, 2023
Humoral signatures of MOG-antibody-associated disease track with age and disease activityMarianna Spatola, Omar Chuquisana, Wonyeong Jung, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 19, 2025
Butyrate modifies epigenetic and immune pathways in peripheral mononuclear cells from children with neurodevelopmental disorders associated with chromatin dysregulationJessica P Hayes, Velda X Han, Brooke A Keating, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2017
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelinationSudarshini Ramanathan, Shekeeb Mohammad, Esther Tantsis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeletonRussell C Dale, Esther M Tantsis, Vera Merheb, et al.
Clinical & Translational Immunology|January 11, 2021
Pro-inflammatory dopamine-2 receptor-specific T cells in paediatric movement and psychiatric disordersDeepti Pilli, Alicia Zou, Ruebena Dawes, et al.
The Pediatric Infectious Disease Journal|April 15, 2025
The Spectrum and Burden of COVID-19-Associated Neurologic Disease in Australian Children 2020-2023Kara DuBray, Katherine Phan, Andrew Anglemyer, et al.
Developmental Medicine and Child Neurology|August 15, 2024
International consensus definitions for infection-triggered encephalopathy syndromesHiroshi Sakuma, Terrence Thomas, Carly Debinski, et al.
Annals of Clinical and Translational Neurology|June 21, 2023
CSF neopterin and quinolinic acid are biomarkers of neuroinflammation and neurotoxicity in FIRES and other infection-triggered encephalopathy syndromesRussell C Dale, Terrence Thomas, Shrujna Patel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 28, 2025
MOG antibody non-P42 epitope is associated with a higher risk of relapse in paediatric MOGADAseel El Hajj, Anne Ruiz, Antoine Gavoille, et al.
Pageof 36

Showing results (271-280 of 353) with videos related to

Sort By:
Pageof 36
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 8, 2026
Cumulative environmental exposures adversely impact social behaviour and are associated with dysregulation of genes and proteins involved in epigenetic, ribosomal, and immune regulation in male miceMorgan C Bucknor, Brooke A Keating, Velda X Han, et al.
Cell Reports. Medicine|January 20, 2023
Humoral signatures of MOG-antibody-associated disease track with age and disease activityMarianna Spatola, Omar Chuquisana, Wonyeong Jung, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 19, 2025
Butyrate modifies epigenetic and immune pathways in peripheral mononuclear cells from children with neurodevelopmental disorders associated with chromatin dysregulationJessica P Hayes, Velda X Han, Brooke A Keating, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2017
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelinationSudarshini Ramanathan, Shekeeb Mohammad, Esther Tantsis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeletonRussell C Dale, Esther M Tantsis, Vera Merheb, et al.
Clinical & Translational Immunology|January 11, 2021
Pro-inflammatory dopamine-2 receptor-specific T cells in paediatric movement and psychiatric disordersDeepti Pilli, Alicia Zou, Ruebena Dawes, et al.
The Pediatric Infectious Disease Journal|April 15, 2025
The Spectrum and Burden of COVID-19-Associated Neurologic Disease in Australian Children 2020-2023Kara DuBray, Katherine Phan, Andrew Anglemyer, et al.
Developmental Medicine and Child Neurology|August 15, 2024
International consensus definitions for infection-triggered encephalopathy syndromesHiroshi Sakuma, Terrence Thomas, Carly Debinski, et al.
Annals of Clinical and Translational Neurology|June 21, 2023
CSF neopterin and quinolinic acid are biomarkers of neuroinflammation and neurotoxicity in FIRES and other infection-triggered encephalopathy syndromesRussell C Dale, Terrence Thomas, Shrujna Patel, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 28, 2025
MOG antibody non-P42 epitope is associated with a higher risk of relapse in paediatric MOGADAseel El Hajj, Anne Ruiz, Antoine Gavoille, et al.
Pageof 36